These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 9810971)

  • 1. Gynaecomastia in association with phenytoin and zonisamide in a patient having a CYP2C subfamily mutation.
    Ikeda A; Hattori H; Odani A; Kimura J; Shibasaki H
    J Neurol Neurosurg Psychiatry; 1998 Nov; 65(5):803-4. PubMed ID: 9810971
    [No Abstract]   [Full Text] [Related]  

  • 2. Two epileptics showing antiepileptic drug-induced psychoses.
    Tsuji M; Hori S; Asai N; Hamanaka T; Ishikawa T; Hiyoshi T; Mochizuki H
    Jpn J Psychiatry Neurol; 1993 Jun; 47(2):298-9. PubMed ID: 8271571
    [No Abstract]   [Full Text] [Related]  

  • 3. [Othello syndrome secondary to zonisamide].
    Rubio-Nazabal E; Alvarez-Pérez P; Lema-Facal T; López-Facal S
    Med Clin (Barc); 2014 Feb; 142(3):133-4. PubMed ID: 23664689
    [No Abstract]   [Full Text] [Related]  

  • 4. Renal tubular acidosis associated with zonisamide therapy.
    Inoue T; Kira R; Kaku Y; Ikeda K; Gondo K; Hara T
    Epilepsia; 2000 Dec; 41(12):1642-4. PubMed ID: 11114225
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Zonisamide-induced suicidal ideation.
    Mago R; Huege S; Ahuja N; Kunkel EJ
    Psychosomatics; 2006; 47(1):68-9. PubMed ID: 16384810
    [No Abstract]   [Full Text] [Related]  

  • 6. Zonisamide approved for partial seizures.
    Am J Health Syst Pharm; 2000 May; 57(9):834, 837. PubMed ID: 10840516
    [No Abstract]   [Full Text] [Related]  

  • 7. Long-term safety and efficacy of zonisamide in patients with refractory partial-onset epilepsy.
    Wroe SJ; Yeates AB; Marshall A
    Acta Neurol Scand; 2008 Aug; 118(2):87-93. PubMed ID: 18547272
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Moderate toxic effects following acute zonisamide overdose.
    Hofer KE; Trachsel C; Rauber-Lüthy C; Kupferschmidt H; Kullak-Ublick GA; Ceschi A
    Epilepsy Behav; 2011 May; 21(1):91-3. PubMed ID: 21463969
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Zonisamide: a review of its use in the management of partial seizures in epilepsy.
    Frampton JE; Scott LJ
    CNS Drugs; 2005; 19(4):347-67. PubMed ID: 15813651
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reversal of MRI lesion with relapse and remission of partial motor seizures in epilepsia partialis continua.
    Fujikawa Y; Kubota H; Matsuda K; Fujiwara T; Yagi K; Seino M
    Jpn J Psychiatry Neurol; 1991 Jun; 45(2):410-2. PubMed ID: 1762232
    [No Abstract]   [Full Text] [Related]  

  • 11. Efficacy and safety of adjunctive zonisamide therapy for refractory partial seizures.
    Baulac M; Leppik IE
    Epilepsy Res; 2007 Jul; 75(2-3):75-83. PubMed ID: 17553670
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of adjunctive zonisamide treatment on weight and body mass index in children with partial epilepsy.
    Lagae L; Meshram C; Giorgi L; Patten A
    Acta Neurol Scand; 2015 May; 131(5):341-6. PubMed ID: 25659828
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective mutism and obsessive compulsive disorders associated with zonisamide.
    Hirai K; Kimiya S; Tabata K; Seki T; Jozaki K; Kumagai N
    Seizure; 2002 Oct; 11(7):468-70. PubMed ID: 12237077
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term safety and efficacy of zonisamide versus carbamazepine monotherapy for treatment of partial seizures in adults with newly diagnosed epilepsy: results of a phase III, randomized, double-blind study.
    Baulac M; Patten A; Giorgi L
    Epilepsia; 2014 Oct; 55(10):1534-43. PubMed ID: 25109239
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of zonisamide monotherapy in a cohort of children with epilepsy.
    Kothare SV; Kaleyias J; Mostofi N; Valencia I; Melvin JJ; Hobdell E; Khurana DS; Legido A
    Pediatr Neurol; 2006 May; 34(5):351-4. PubMed ID: 16647993
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Review of United States and European clinical trials of zonisamide in the treatment of refractory partial-onset seizures.
    Faught E
    Seizure; 2004 Dec; 13 Suppl 1():S59-65; discussion S71-2. PubMed ID: 15511695
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized controlled trial of zonisamide for the treatment of partial-onset seizures.
    Haruda FD
    Neurology; 2002 Jun; 58(11):1704-5; author reply 1705. PubMed ID: 12058113
    [No Abstract]   [Full Text] [Related]  

  • 18. Psychosis induced by zonisamide: a case report and review of the literature.
    Abdoh M; Mersfelder TL; Melgar TA
    Am J Ther; 2014; 21(1):e15-6. PubMed ID: 22020087
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phenytoin desensitization in a child with symptomatic localization-related epilepsy.
    Itomi S; Okumura A; Ikuta T; Negoro T; Watanabe K
    Brain Dev; 2007 Mar; 29(2):121-3. PubMed ID: 16935446
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The interaction of denzimol (a new anticonvulsant) with carbamazepine and phenytoin.
    Patsalos PN; Shorvon SD; Elyas AA; Smith G
    J Neurol Neurosurg Psychiatry; 1985 Apr; 48(4):374-7. PubMed ID: 3923158
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.